MTD vs TKNO: fair value comparison
Mettler-Toledo International Inc. and Alpha Teknova, Inc. · Updated 2026-10-19
TKNO has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, MTD currently ranks higher by quality score.
| MTD | TKNO | |
|---|---|---|
| Verdict | Fairly valued | No estimate yet |
| Last price | $1,549.99 | $7.08 |
| 12-month range | $1,025.53–$1,639.04 | $1.99–$9.33 |
| Rank by discount to fair value | #52 of 108 Healthcare | — |
| Rank by quality score | #121 of 301 Healthcare | #123 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | High | Low |
| Margin trend | Expanding | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Uptrend |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: MTD fair value analysis · TKNO fair value analysis